PEPTONIC MEDICAL Stock Price Today
PEPTONIC MEDICAL stock price today. PEPTONIC MEDICAL (F:28L) is currently trading at €0.00 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.00. This page tracks PEPTONIC MEDICAL's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see how efficiently does PEPTONIC MEDICAL generate cash.
Share Price of PEPTONIC MEDICAL — Daily History & Trading Volume
Share price of PEPTONIC MEDICAL over the past year. The chart below tracks PEPTONIC MEDICAL's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
PEPTONIC MEDICAL Stock Trading Volume
PEPTONIC MEDICAL stock trading volume shows how many shares changed hands each day on the F exchange.
PEPTONIC MEDICAL Income Statement — Revenue, Profit & Earnings by Year
PEPTONIC MEDICAL's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €14.79 Million | €26.89 Million | €37.12 Million | €43.63 Million | €31.64 Million |
| Cost of Revenue | €4.83 Million | €11.73 Million | €20.82 Million | €20.24 Million | €12.57 Million |
| Gross Profit | €9.95 Million | €15.16 Million | €16.30 Million | €23.39 Million | €19.07 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | — | €45.69 Million |
| Total Operating Expenses | €34.24 Million | €67.49 Million | €78.30 Million | €77.24 Million | €105.36 Million |
| Operating Income | €-19.45 Million | €-40.60 Million | €-41.19 Million | €-33.61 Million | €-73.72 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €3.09 Million | €1.41 Million | €2.32 Million | €5.56 Million | €72.00K |
| Income Before Tax | €-22.50 Million | €-60.03 Million | €-42.59 Million | €-36.86 Million | €-73.69 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-22.50 Million | €-60.03 Million | €-42.59 Million | €-36.86 Million | €-73.69 Million |
PEPTONIC MEDICAL Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PEPTONIC MEDICAL's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €65.92 Million | €70.56 Million | €106.74 Million | €85.75 Million | €84.60 Million |
| Total Current Assets | €13.64 Million | €12.59 Million | €40.41 Million | €31.35 Million | €28.19 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | — | — | €4.13 Million | €7.24 Million | €5.17 Million |
| Inventory | €5.62 Million | €4.99 Million | €16.00 Million | €15.37 Million | €10.29 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €3.30 Million | €4.46 Million | €5.63 Million | €0.00 | €0.00 |
| Total Liabilities | €27.67 Million | €22.01 Million | €31.41 Million | €38.66 Million | €31.48 Million |
| Total Current Liabilities | €27.67 Million | €22.01 Million | €31.41 Million | €35.06 Million | €31.48 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | €9.23 Million | €8.84 Million | — | €15.77 Million | €5.19 Million |
| Total Stockholder Equity | €38.24 Million | €48.55 Million | €75.32 Million | €47.09 Million | €53.12 Million |
| Retained Earnings | €-378.73 Million | €-355.82 Million | €-301.47 Million | €-258.19 Million | €-224.10 Million |
PEPTONIC MEDICAL Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PEPTONIC MEDICAL generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-20.50 Million | €-37.55 Million | €-33.81 Million | €-40.22 Million | €-40.34 Million |
| Capital Expenditures | €162.00K | €1.20 Million | €1.93 Million | €987.00K | €4.28 Million |
| Free Cash Flow | €-20.66 Million | €-38.76 Million | €-35.74 Million | €-41.20 Million | €-44.62 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | — | — | — | — | — |
| Change in Cash | €-2.85 Million | €-12.13 Million | €11.57 Million | €-6.59 Million | €-29.16 Million |
PEPTONIC MEDICAL Earnings History — EPS Actual vs. Analyst Estimates
Track PEPTONIC MEDICAL's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for PEPTONIC MEDICAL.